Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

Related Citations for PubMed (Select 21695638)

1.

A fission yeast-based platform for phosphodiesterase inhibitor HTSs and analyses of phosphodiesterase activity.

Demirbas D, Ceyhan O, Wyman AR, Hoffman CS.

Handb Exp Pharmacol. 2011;(204):135-49. doi: 10.1007/978-3-642-17969-3_5. Review.

PMID:
21695638
2.

Development of a fission yeast-based high-throughput screen to identify chemical regulators of cAMP phosphodiesterases.

Ivey FD, Wang L, Demirbas D, Allain C, Hoffman CS.

J Biomol Screen. 2008 Jan;13(1):62-71. doi: 10.1177/1087057107312127.

3.

Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen.

Ceyhan O, Birsoy K, Hoffman CS.

Chem Biol. 2012 Jan 27;19(1):155-63. doi: 10.1016/j.chembiol.2011.12.010.

4.

Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.

Cheng J, Grande JP.

Exp Biol Med (Maywood). 2007 Jan;232(1):38-51. Review.

PMID:
17202584
5.

New classes of PDE7 inhibitors identified by a fission yeast-based HTS.

Alaamery MA, Wyman AR, Ivey FD, Allain C, Demirbas D, Wang L, Ceyhan O, Hoffman CS.

J Biomol Screen. 2010 Apr;15(4):359-67. doi: 10.1177/1087057110362100. Epub 2010 Mar 12.

6.

Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.

Willette RN, Shiloh AO, Sauermelch CF, Sulpizio A, Michell MP, Cieslinski LB, Torphy TJ, Ohlstein EH.

J Cereb Blood Flow Metab. 1997 Feb;17(2):210-9.

7.

Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.

Qiu Y, Kraft P, Lombardi E, Clancy J.

J Urol. 2000 Sep;164(3 Pt 1):882-6.

PMID:
10953172
8.

Cloning and characterization of a cAMP-specific phosphodiesterase (TbPDE2B) from Trypanosoma brucei.

Rascón A, Soderling SH, Schaefer JB, Beavo JA.

Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4714-9.

9.

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use.

Bender AT, Beavo JA.

Pharmacol Rev. 2006 Sep;58(3):488-520. Review.

11.

Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.

Marko D, Romanakis K, Zankl H, Fürstenberger G, Steinbauer B, Eisenbrand G.

Cell Biochem Biophys. 1998;28(2-3):75-101.

PMID:
9515161
12.
13.
14.

Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer.

Hamilton TK, Hu N, Kolomitro K, Bell EN, Maurice DH, Graham CH, Siemens DR.

World J Urol. 2013 Apr;31(2):325-30. doi: 10.1007/s00345-012-0848-7. Epub 2012 Mar 2.

PMID:
22383129
15.

Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents.

Lugnier C.

Pharmacol Ther. 2006 Mar;109(3):366-98. Epub 2005 Aug 15. Review.

PMID:
16102838
16.

Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.

Simmons MA, Hartzell HC.

Mol Pharmacol. 1988 Jun;33(6):664-71. Erratum in: Mol Pharmacol 1988 Oct;34(4):604.

PMID:
2454387
17.

Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle.

Torphy TJ, Undem BJ, Cieslinski LB, Luttmann MA, Reeves ML, Hay DW.

J Pharmacol Exp Ther. 1993 Jun;265(3):1213-23.

PMID:
8389856
18.

An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.

Gupta R, Kumar G, Kumar RS.

Methods Find Exp Clin Pharmacol. 2005 Mar;27(2):101-18. Review.

PMID:
15834463
19.

Use of a Schizosaccharomyces pombe PKA-repressible reporter to study cGMP metabolising phosphodiesterases.

Demirbas D, Ceyhan O, Wyman AR, Ivey FD, Allain C, Wang L, Sharuk MN, Francis SH, Hoffman CS.

Cell Signal. 2011 Mar;23(3):594-601. doi: 10.1016/j.cellsig.2010.11.013. Epub 2010 Nov 29.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk